Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation
Open Access
- 21 February 2011
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 208 (3), 479-490
- https://doi.org/10.1084/jem.20102131
Abstract
TSLP released from human breast cancer cells promotes OX40L expression on DCs, and these OX40L-expressing DCs drive development of inflammatory Th2 cells which promote breast tumor development.Keywords
This publication has 63 references indexed in Scilit:
- Sensing the outside world: TSLP regulates barrier immunityNature Immunology, 2010
- Immunity, Inflammation, and CancerCell, 2010
- CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of MacrophagesCancer Cell, 2009
- Toll-like receptors and cancerNature Reviews Cancer, 2008
- Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic CellsImmunity, 2008
- ATM Gene Mutations Result in Both Recessive and Dominant Expression Phenotypes of Genes and MicroRNAsAmerican Journal of Human Genetics, 2008
- Breast cancer instructs dendritic cells to prime interleukin 13–secreting CD4+ T cells that facilitate tumor developmentThe Journal of Experimental Medicine, 2007
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCancer Cell, 2006
- Inflammation and cancerNature, 2002
- Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLPNature Immunology, 2002